VTE outcomes:
All patients with documented thrombosis received therapeutic anticoagulation with at least 1 of the following: unfractionated heparin (n=7, 33%), low molecular weight heparin ([LMWH], n=21, 100%), warfarin (n=2, 9%), rivaroxaban (n=2, 9%), or apixaban (n=1, 5%). Only 1 patient (with PE and lower extremity DVT) additionally underwent catheter-directed thrombolysis and mechanical thrombectomy. All patients (n=21, 100%) had resolution of the primary VTE on imaging after 12 weeks of therapeutic anticoagulation. The rate of major bleeding was 10%. There was 1 death (5%), and it is thought that this patient likely died from showered emboli causing a PE and cardiorespiratory arrest that occurred shortly after the central line was pulled.